<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d327" origId="Amoxapine"><sentence id="DrugDDI.d327.s0" origId="s0" text="Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic drugs."><entity id="DrugDDI.d327.s0.e0" origId="s0.p5" charOffset="45-70" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d327.s0.e1" origId="s0.p7" charOffset="91-112" type="drug" text="anticholinergic drugs"/><pair id="DrugDDI.d327.s0.p0" e1="DrugDDI.d327.s0.e0" e2="DrugDDI.d327.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d327.s1" origId="s1" text="Amoxapine may enhance the response to alcohol and the effects of barbiturates and other CNS depressants."><entity id="DrugDDI.d327.s1.e0" origId="s1.p8" charOffset="0-9" type="drug" text="Amoxapine"/><entity id="DrugDDI.d327.s1.e1" origId="s1.p12" charOffset="38-45" type="drug" text="alcohol"/><entity id="DrugDDI.d327.s1.e2" origId="s1.p15" charOffset="65-77" type="drug" text="barbiturates"/><entity id="DrugDDI.d327.s1.e3" origId="s1.p17" charOffset="88-103" type="drug" text="CNS depressants"/><pair id="DrugDDI.d327.s1.p0" e1="DrugDDI.d327.s1.e0" e2="DrugDDI.d327.s1.e1" interaction="true"/><pair id="DrugDDI.d327.s1.p1" e1="DrugDDI.d327.s1.e0" e2="DrugDDI.d327.s1.e2" interaction="false"/><pair id="DrugDDI.d327.s1.p2" e1="DrugDDI.d327.s1.e0" e2="DrugDDI.d327.s1.e3" interaction="true"/><pair id="DrugDDI.d327.s1.p3" e1="DrugDDI.d327.s1.e1" e2="DrugDDI.d327.s1.e2" interaction="false"/><pair id="DrugDDI.d327.s1.p4" e1="DrugDDI.d327.s1.e1" e2="DrugDDI.d327.s1.e3" interaction="false"/><pair id="DrugDDI.d327.s1.p5" e1="DrugDDI.d327.s1.e2" e2="DrugDDI.d327.s1.e3" interaction="false"/></sentence><sentence id="DrugDDI.d327.s2" origId="s2" text="Serum levels of several tricyclic antidepressants have been reported to be significantly increased when cimetidine is administered concurrently Although such an interaction has not been reported to date with amoxapine, specific interaction studies have not been done, and the possibility should be considered."><entity id="DrugDDI.d327.s2.e0" origId="s2.p19" charOffset="24-49" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d327.s2.e1" origId="s2.p28" charOffset="104-114" type="drug" text="cimetidine"/><entity id="DrugDDI.d327.s2.e2" origId="s2.p40" charOffset="208-217" type="drug" text="amoxapine"/><pair id="DrugDDI.d327.s2.p0" e1="DrugDDI.d327.s2.e0" e2="DrugDDI.d327.s2.e1" interaction="true"/><pair id="DrugDDI.d327.s2.p1" e1="DrugDDI.d327.s2.e0" e2="DrugDDI.d327.s2.e2" interaction="false"/><pair id="DrugDDI.d327.s2.p2" e1="DrugDDI.d327.s2.e1" e2="DrugDDI.d327.s2.e2" interaction="false"/></sentence><sentence id="DrugDDI.d327.s3" origId="s3" text="Drugs Metabolized by P450 2D6"><entity id="DrugDDI.d327.s3.e0" origId="s3.p52" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d327.s3.e1" origId="s3.p54" charOffset="21-30" type="drug" text="P450 2D6"/><pair id="DrugDDI.d327.s3.p0" e1="DrugDDI.d327.s3.e0" e2="DrugDDI.d327.s3.e1" interaction="false"/></sentence><sentence id="DrugDDI.d327.s4" origId="s4" text="The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (dehrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7 to 10% of caucasians are so called of reduced P450 2D6 isozyme activity among p.o. metabolizers);"><entity id="DrugDDI.d327.s4.e0" origId="s4.p56" charOffset="32-36" type="drug" text="drug"/><entity id="DrugDDI.d327.s4.e1" origId="s4.p58" charOffset="91-102" type="drug" text="hydroxylase"/><entity id="DrugDDI.d327.s4.e2" origId="s4.p71" charOffset="210-227" type="drug" text="P450 2D6 isozyme"/><pair id="DrugDDI.d327.s4.p0" e1="DrugDDI.d327.s4.e0" e2="DrugDDI.d327.s4.e1" interaction="false"/><pair id="DrugDDI.d327.s4.p1" e1="DrugDDI.d327.s4.e0" e2="DrugDDI.d327.s4.e2" interaction="false"/><pair id="DrugDDI.d327.s4.p2" e1="DrugDDI.d327.s4.e1" e2="DrugDDI.d327.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d327.s5" origId="s5" text="reliable estimates of the prevalence Asian, African and other populatlons are not yet available when given usual doses."/><sentence id="DrugDDI.d327.s6" origId="s6" text="Poor metabolizers have higher than expected plasma concentrations tricyclic antidepressants (TCAs) when given usual doses."><entity id="DrugDDI.d327.s6.e0" origId="s6.p87" charOffset="66-91" type="drug" text="tricyclic antidepressants"/></sentence><sentence id="DrugDDI.d327.s7" origId="s7" text="Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."><entity id="DrugDDI.d327.s7.e0" origId="s7.p95" charOffset="29-33" type="drug" text="drug"/><entity id="DrugDDI.d327.s7.e1" origId="s7.p97" charOffset="49-58" type="drug" text="P450 2D6"/><pair id="DrugDDI.d327.s7.p0" e1="DrugDDI.d327.s7.e0" e2="DrugDDI.d327.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d327.s8" origId="s8" text="In addition certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble p.o. metabolizers."><entity id="DrugDDI.d327.s8.e0" origId="s8.p110" charOffset="20-25" type="drug" text="drugs"/><entity id="DrugDDI.d327.s8.e1" origId="s8.p113" charOffset="55-62" type="drug" text="isozyme"/><pair id="DrugDDI.d327.s8.p0" e1="DrugDDI.d327.s8.e0" e2="DrugDDI.d327.s8.e1" interaction="true"/></sentence><sentence id="DrugDDI.d327.s9" origId="s9" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy."><entity id="DrugDDI.d327.s9.e0" origId="s9.p130" charOffset="112-117" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d327.s10" origId="s10" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzymes quinidine, cimetidine, and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."><entity id="DrugDDI.d327.s10.e0" origId="s10.p132" charOffset="4-9" type="drug" text="drugs"/><entity id="DrugDDI.d327.s10.e1" origId="s10.p135" charOffset="23-42" type="drug" text="cytochrome P450 2D6"/><entity id="DrugDDI.d327.s10.e2" origId="s10.p142" charOffset="96-105" type="drug" text="quinidine"/><entity id="DrugDDI.d327.s10.e3" origId="s10.p143" charOffset="107-117" type="drug" text="cimetidine"/><entity id="DrugDDI.d327.s10.e4" origId="s10.p149" charOffset="152-161" type="drug" text="P450 2D6"/><entity id="DrugDDI.d327.s10.e5" origId="s10.p151" charOffset="173-188" type="drug" text="antidepressants"/><entity id="DrugDDI.d327.s10.e6" origId="s10.p152" charOffset="190-204" type="drug" text="phenothiazines"/><entity id="DrugDDI.d327.s10.e7" origId="s10.p154" charOffset="238-249" type="drug" text="propafenone"/><entity id="DrugDDI.d327.s10.e8" origId="s10.p156" charOffset="254-264" type="drug" text="flecainide"/><pair id="DrugDDI.d327.s10.p0" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e1" interaction="false"/><pair id="DrugDDI.d327.s10.p1" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e2" interaction="false"/><pair id="DrugDDI.d327.s10.p2" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e3" interaction="false"/><pair id="DrugDDI.d327.s10.p3" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e4" interaction="false"/><pair id="DrugDDI.d327.s10.p4" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e5" interaction="false"/><pair id="DrugDDI.d327.s10.p5" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p6" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p7" e1="DrugDDI.d327.s10.e0" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p8" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e2" interaction="false"/><pair id="DrugDDI.d327.s10.p9" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e3" interaction="false"/><pair id="DrugDDI.d327.s10.p10" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e4" interaction="false"/><pair id="DrugDDI.d327.s10.p11" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e5" interaction="false"/><pair id="DrugDDI.d327.s10.p12" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p13" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p14" e1="DrugDDI.d327.s10.e1" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p15" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e3" interaction="false"/><pair id="DrugDDI.d327.s10.p16" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e4" interaction="false"/><pair id="DrugDDI.d327.s10.p17" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e5" interaction="false"/><pair id="DrugDDI.d327.s10.p18" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p19" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p20" e1="DrugDDI.d327.s10.e2" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p21" e1="DrugDDI.d327.s10.e3" e2="DrugDDI.d327.s10.e4" interaction="false"/><pair id="DrugDDI.d327.s10.p22" e1="DrugDDI.d327.s10.e3" e2="DrugDDI.d327.s10.e5" interaction="false"/><pair id="DrugDDI.d327.s10.p23" e1="DrugDDI.d327.s10.e3" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p24" e1="DrugDDI.d327.s10.e3" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p25" e1="DrugDDI.d327.s10.e3" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p26" e1="DrugDDI.d327.s10.e4" e2="DrugDDI.d327.s10.e5" interaction="false"/><pair id="DrugDDI.d327.s10.p27" e1="DrugDDI.d327.s10.e4" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p28" e1="DrugDDI.d327.s10.e4" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p29" e1="DrugDDI.d327.s10.e4" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p30" e1="DrugDDI.d327.s10.e5" e2="DrugDDI.d327.s10.e6" interaction="false"/><pair id="DrugDDI.d327.s10.p31" e1="DrugDDI.d327.s10.e5" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p32" e1="DrugDDI.d327.s10.e5" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p33" e1="DrugDDI.d327.s10.e6" e2="DrugDDI.d327.s10.e7" interaction="false"/><pair id="DrugDDI.d327.s10.p34" e1="DrugDDI.d327.s10.e6" e2="DrugDDI.d327.s10.e8" interaction="false"/><pair id="DrugDDI.d327.s10.p35" e1="DrugDDI.d327.s10.e7" e2="DrugDDI.d327.s10.e8" interaction="false"/></sentence><sentence id="DrugDDI.d327.s11" origId="s11" text="While all the selective serotonin reuptake inhibitors (SSRls), e.g. fluoxetine, sertraline, and paroxetine inhibit P450 2D6, they may vary in the extent of inhibition."><entity id="DrugDDI.d327.s11.e0" origId="s11.p160" charOffset="24-53" type="drug" text="serotonin reuptake inhibitors"/><entity id="DrugDDI.d327.s11.e1" origId="s11.p166" charOffset="68-78" type="drug" text="fluoxetine"/><entity id="DrugDDI.d327.s11.e2" origId="s11.p167" charOffset="80-90" type="drug" text="sertraline"/><entity id="DrugDDI.d327.s11.e3" origId="s11.p169" charOffset="96-106" type="drug" text="paroxetine"/><entity id="DrugDDI.d327.s11.e4" origId="s11.p171" charOffset="115-124" type="drug" text="P450 2D6"/><pair id="DrugDDI.d327.s11.p0" e1="DrugDDI.d327.s11.e0" e2="DrugDDI.d327.s11.e1" interaction="false"/><pair id="DrugDDI.d327.s11.p1" e1="DrugDDI.d327.s11.e0" e2="DrugDDI.d327.s11.e2" interaction="false"/><pair id="DrugDDI.d327.s11.p2" e1="DrugDDI.d327.s11.e0" e2="DrugDDI.d327.s11.e3" interaction="false"/><pair id="DrugDDI.d327.s11.p3" e1="DrugDDI.d327.s11.e0" e2="DrugDDI.d327.s11.e4" interaction="true"/><pair id="DrugDDI.d327.s11.p4" e1="DrugDDI.d327.s11.e1" e2="DrugDDI.d327.s11.e2" interaction="false"/><pair id="DrugDDI.d327.s11.p5" e1="DrugDDI.d327.s11.e1" e2="DrugDDI.d327.s11.e3" interaction="false"/><pair id="DrugDDI.d327.s11.p6" e1="DrugDDI.d327.s11.e1" e2="DrugDDI.d327.s11.e4" interaction="false"/><pair id="DrugDDI.d327.s11.p7" e1="DrugDDI.d327.s11.e2" e2="DrugDDI.d327.s11.e3" interaction="false"/><pair id="DrugDDI.d327.s11.p8" e1="DrugDDI.d327.s11.e2" e2="DrugDDI.d327.s11.e4" interaction="true"/><pair id="DrugDDI.d327.s11.p9" e1="DrugDDI.d327.s11.e3" e2="DrugDDI.d327.s11.e4" interaction="false"/></sentence><sentence id="DrugDDI.d327.s12" origId="s12" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokmetics of the SSRI involved."/><sentence id="DrugDDI.d327.s13" origId="s13" text="Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other of particular importance."/><sentence id="DrugDDI.d327.s14" origId="s14" text="Sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine given."><entity id="DrugDDI.d327.s14.e0" origId="s14.p212" charOffset="94-104" type="drug" text="fluoxetine"/></sentence><sentence id="DrugDDI.d327.s15" origId="s15" text="The long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."><entity id="DrugDDI.d327.s15.e0" origId="s15.p217" charOffset="37-54" type="drug" text="active metabolite"/></sentence><sentence id="DrugDDI.d327.s16" origId="s16" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug."><entity id="DrugDDI.d327.s16.e0" origId="s16.p225" charOffset="19-44" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d327.s16.e1" origId="s16.p226" charOffset="50-55" type="drug" text="drugs"/><entity id="DrugDDI.d327.s16.e2" origId="s16.p230" charOffset="73-92" type="drug" text="cytochrome P450 2D6"/><entity id="DrugDDI.d327.s16.e3" origId="s16.p238" charOffset="156-180" type="drug" text="tricyclic antidepressant"/><entity id="DrugDDI.d327.s16.e4" origId="s16.p240" charOffset="194-198" type="drug" text="drug"/><pair id="DrugDDI.d327.s16.p0" e1="DrugDDI.d327.s16.e0" e2="DrugDDI.d327.s16.e1" interaction="true"/><pair id="DrugDDI.d327.s16.p1" e1="DrugDDI.d327.s16.e0" e2="DrugDDI.d327.s16.e2" interaction="false"/><pair id="DrugDDI.d327.s16.p2" e1="DrugDDI.d327.s16.e0" e2="DrugDDI.d327.s16.e3" interaction="false"/><pair id="DrugDDI.d327.s16.p3" e1="DrugDDI.d327.s16.e0" e2="DrugDDI.d327.s16.e4" interaction="false"/><pair id="DrugDDI.d327.s16.p4" e1="DrugDDI.d327.s16.e1" e2="DrugDDI.d327.s16.e2" interaction="false"/><pair id="DrugDDI.d327.s16.p5" e1="DrugDDI.d327.s16.e1" e2="DrugDDI.d327.s16.e3" interaction="false"/><pair id="DrugDDI.d327.s16.p6" e1="DrugDDI.d327.s16.e1" e2="DrugDDI.d327.s16.e4" interaction="false"/><pair id="DrugDDI.d327.s16.p7" e1="DrugDDI.d327.s16.e2" e2="DrugDDI.d327.s16.e3" interaction="false"/><pair id="DrugDDI.d327.s16.p8" e1="DrugDDI.d327.s16.e2" e2="DrugDDI.d327.s16.e4" interaction="false"/><pair id="DrugDDI.d327.s16.p9" e1="DrugDDI.d327.s16.e3" e2="DrugDDI.d327.s16.e4" interaction="false"/></sentence><sentence id="DrugDDI.d327.s17" origId="s17" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."><entity id="DrugDDI.d327.s17.e0" origId="s17.p244" charOffset="41-46" type="drug" text="drugs"/><entity id="DrugDDI.d327.s17.e1" origId="s17.p249" charOffset="98-122" type="drug" text="tricyclic antidepressant"/><pair id="DrugDDI.d327.s17.p0" e1="DrugDDI.d327.s17.e0" e2="DrugDDI.d327.s17.e1" interaction="false"/></sentence><sentence id="DrugDDI.d327.s18" origId="s18" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6."><entity id="DrugDDI.d327.s18.e0" origId="s18.p265" charOffset="104-108" type="drug" text="drug"/><entity id="DrugDDI.d327.s18.e1" origId="s18.p270" charOffset="137-146" type="drug" text="P450 2D6"/><pair id="DrugDDI.d327.s18.p0" e1="DrugDDI.d327.s18.e0" e2="DrugDDI.d327.s18.e1" interaction="false"/></sentence><sentence id="DrugDDI.d327.s19" origId="s19" text="Therapeutic Interactions"/><sentence id="DrugDDI.d327.s20" origId="s20" text="Concurrent administration with electroshock therapy may increase the hazards associated with such therapy."/></document>